Clinical Trial Update: A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating MK-4716 in people with certain solid tumors, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• MK-4716

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Malignant Neoplasm | Phase 1 | Status: RECRUITING